When does Thermo Fisher Scientific Inc. (TMO) report earnings? Before the open in 12 of its last 12 reports
Of its last 12 earnings announcements: 12 before the open. Each one comes from the 8-K with item 2.02 that Thermo Fisher Scientific filed with the SEC, paired with the 10-Q or 10-K for that same quarter: 66 quarters since Jul 23, 2009, and every row links to its filing.
Next date: the one TMO had announced, Oct 21, 2026, has already happened and its 8-K is filed (below). There is no further date yet inside the calendar this site covers (Oct 21, 2026 to Nov 24, 2026).
The latest, still without a report
- Oct 21, 2026, Wednesday at 06:03 New York time (before the open). see the 8-K
It is this company's most recent 8-K with item 2.02 and it does not yet have its 10-Q or 10-K behind it, so there is no way to say which quarter it belongs to: it does not enter the figures above or the table, and for the same reason it might not be an earnings announcement at all (some companies use this same item for production figures or monthly sales).
The last 20 quarters, one by one
"Lead": trading sessions between the announcement and the full quarterly report to the SEC (10-Q, or 10-K at fiscal year end). For Thermo Fisher Scientific, a median of 7 sessions over the last 12 quarters.
| Announcement | Day | Time (NY) | Session | Quarter ended | SEC report | Lead | Filing |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | Thursday | 06:04 | before the open | Jun 27, 2026 | 10-Q · Jul 31, 2026 | 6 sessions | 8-K |
| Apr 23, 2026 | Thursday | 06:03 | before the open | Mar 28, 2026 | 10-Q · May 1, 2026 | 6 sessions | 8-K |
| Jan 29, 2026 | Thursday | 06:02 | before the open | Dec 31, 2025 | 10-K · Feb 26, 2026 | 19 sessions | 8-K |
| Oct 22, 2025 | Wednesday | 06:05 | before the open | Sep 27, 2025 | 10-Q · Oct 31, 2025 | 7 sessions | 8-K |
| Jul 23, 2025 | Wednesday | 06:03 | before the open | Jun 28, 2025 | 10-Q · Aug 1, 2025 | 7 sessions | 8-K |
| Apr 23, 2025 | Wednesday | 06:04 | before the open | Mar 29, 2025 | 10-Q · May 2, 2025 | 7 sessions | 8-K |
| Jan 30, 2025 | Thursday | 06:03 | before the open | Dec 31, 2024 | 10-K · Feb 20, 2025 | 14 sessions | 8-K |
| Oct 23, 2024 | Wednesday | 06:03 | before the open | Sep 28, 2024 | 10-Q · Nov 1, 2024 | 7 sessions | 8-K |
| Jul 24, 2024 | Wednesday | 06:03 | before the open | Jun 29, 2024 | 10-Q · Aug 2, 2024 | 7 sessions | 8-K |
| Apr 24, 2024 | Wednesday | 06:03 | before the open | Mar 30, 2024 | 10-Q · May 3, 2024 | 7 sessions | 8-K |
| Jan 31, 2024 | Wednesday | 06:02 | before the open | Dec 31, 2023 | 10-K · Feb 22, 2024 | 15 sessions | 8-K |
| Oct 25, 2023 | Wednesday | 06:03 | before the open | Sep 30, 2023 | 10-Q · Nov 3, 2023 | 7 sessions | 8-K |
| Jul 26, 2023 | Wednesday | 06:02 | before the open | Jul 1, 2023 | 10-Q · Aug 4, 2023 | 7 sessions | 8-K |
| Apr 26, 2023 | Wednesday | 06:04 | before the open | Apr 1, 2023 | 10-Q · May 5, 2023 | 7 sessions | 8-K |
| Feb 1, 2023 | Wednesday | 06:05 | before the open | Dec 31, 2022 | 10-K · Feb 23, 2023 | 15 sessions | 8-K |
| Oct 26, 2022 | Wednesday | 06:07 | before the open | Oct 1, 2022 | 10-Q · Nov 4, 2022 | 7 sessions | 8-K |
| Jul 28, 2022 | Thursday | 06:08 | before the open | Jul 2, 2022 | 10-Q · Aug 5, 2022 | 6 sessions | 8-K |
| Apr 28, 2022 | Thursday | 06:04 | before the open | Apr 2, 2022 | 10-Q · May 6, 2022 | 6 sessions | 8-K |
| Feb 2, 2022 | Wednesday | 06:09 | before the open | Dec 31, 2021 | 10-K · Feb 24, 2022 | 15 sessions | 8-K |
| Oct 27, 2021 | Wednesday | 06:06 | before the open | Oct 2, 2021 | 10-Q · Nov 4, 2021 | 6 sessions | 8-K |
The table shows the 20 most recent quarters. All 66 are in the CSV, with the same columns and one row per quarter.
Download all 66 TMO quarters as CSV → Free, no account.
How Thermo Fisher Scientific shares moved on their latest earnings
Over the 8 announcements with prices in this table, TMO rose 4 times and fell 4 times; the median move, ignoring sign, was 4.7%, against 0.7% for SPY over the same windows. The largest, −9.2%, came with the results of Apr 23, 2026. Reported EPS beat the consensus estimate in 5 of the 5 quarters with an estimate.
| Announcement | Session | Window, close to close | TMO | SPY | EPS actual / expected |
|---|---|---|---|---|---|
| Jul 23, 2026 | before the open | Jul 22, 2026 → Jul 23, 2026 | +8.7% | −1.2% | 6.03 / 5.71 (+5.5%) |
| Apr 23, 2026 | before the open | Apr 22, 2026 → Apr 23, 2026 | −9.2% | −0.4% | 5.44 / 5.24 (+3.8%) |
| Jan 29, 2026 | before the open | Jan 28, 2026 → Jan 29, 2026 | −2.6% | −0.2% | 6.57 / 6.45 (+1.9%) |
| Oct 22, 2025 | before the open | Oct 21, 2025 → Oct 22, 2025 | +1.7% | −0.5% | 5.79 / 5.5 (+5.3%) |
| Jul 23, 2025 | before the open | Jul 22, 2025 → Jul 23, 2025 | +9.1% | +0.9% | 5.36 / 5.23 (+2.5%) |
| Apr 23, 2025 | before the open | Apr 22, 2025 → Apr 23, 2025 | −0.7% | +1.5% | |
| Jan 30, 2025 | before the open | Jan 29, 2025 → Jan 30, 2025 | +6.8% | +0.5% | |
| Oct 23, 2024 | before the open | Oct 22, 2024 → Oct 23, 2024 | −1.7% | −0.9% |
TMO window: when it reported before the open or during market hours, from the previous close to that day's. Split-adjusted closes and EPS with its estimate, from Yahoo Finance. It already happened: it does not anticipate the next announcement.
Where each number comes from
From the 8-K with item 2.02 ("Results of Operations and Financial Condition") that Thermo Fisher Scientific filed on EDGAR, the SEC's public database; only those with their 10-Q or 10-K behind them count, so other 8-Ks with the same item (production figures, monthly sales) stay out. The time is converted to New York time using this specific company's stamp convention (its EDGAR stamp arrives in UTC), and it is not assumed: it is derived from the hours in which EDGAR accepts filings.
What this data does not know
- The exact time of the press release: the 8-K reaches EDGAR minutes or hours later, so Thermo Fisher Scientific's median 06:03 is an upper bound. The session says which one the news landed in, not what minute it was said.
- Nothing before Jul 23, 2009: it is Thermo Fisher Scientific's oldest quarter with announcement and report paired in the file.
- What will happen. Every date on the page already happened. Thermo Fisher Scientific reporting before the open 42 quarters in a row does not say the next one will be the same.
- Thermo Fisher Scientific's identity is its SEC CIK (0000097745), not its symbol: symbols get recycled and renamed.
When other Healthcare companies report earnings
- MRNA
- LLY
- INCY
- CAH
- ELV
- SOLV
- BMY
- DXCM
- CVS
- HSIC
- VTRS
- JNJ
- DVA
- UHS
- CI
- BIIB
- VRTX
- REGN
- CNC
- MRK
- EW
- HUM
- MCK
- COR
- AMGN
- WAT
- WST
- TECH
- ABBV
- IDXX
- DGX
- RVTY
- MTD
- A
- ZBH
- ISRG
- ALGN
- HCA
- UNH
- COO
- BDX
- VEEV
- MDT
- DHR
- PFE
- LH
- RMD
- IQV
- GEHC
- STE
- PODD
- BSX
- SYK
- BAX
- CRL
- ZTS
- ABT
- GILD
- DHI
- NDAQ
More on Thermo Fisher Scientific
Thermo Fisher Scientific is in the Healthcare sector. On the model's multifactor score of Oct 21, 2026 it ranks 264 of 464, and 34 of the 55 companies in its sector that score. It is a quantitative model ranking, not a recommendation.
Thermo Fisher Scientific (TMO) analysis page →
All ~500 S&P 500 companies, sorted by when they report →
Guide: 10-K, 10-Q and 8-K · all guides
What is behind these dates
The concepts on this page, explained from scratch in the Academy. Free, no account.
- Guessing next quarter's earnings gives no edgeWhy knowing a quarter's earnings in advance is not enough to make money: what moves the price is the gap against what was expected.
- Supply, demand and price: why it rises and falls constantlyWhat happens to the price on announcement day, and why excellent results can leave the stock falling.
- The three financial statements of a companyWhat is inside the 10-Q and the 10-K whose lag behind the announcement this page measures.
- Point-in-time data and look-ahead biasWhy the date a figure became public matters as much as the figure, which is exactly the distinction behind the two date columns above.
Source: EDGAR, the SEC's public database (forms 8-K, 10-Q and 10-K). Data through Oct 21, 2026. This is a list of public facts and of calculations made on them, not financial advice or a recommendation to buy or sell.